Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NASDAQ:TXMD)

6.05
Delayed Data
As of 4:00pm ET
 +0.06 / +1.00%
Today’s Change
3.50
Today|||52-Week Range
8.30
+4.85%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.99
Today’s open6.00
Day’s range5.94 - 6.10
Volume8,582
Average volume (3 months)3,021,942
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book9.24

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...+0.05+0.13%
ESPREsperion Therapeutic...+0.23+0.41%
BHVNBiohaven Pharmaceuti...+0.36+1.43%
FWPForward Pharma A/S+0.14+3.14%
Data as of 4:02pm ET, 11/22/2017

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts